Multiple Sclerosis Part 1 : Essentials and the McDonald Criteria
Copyright © 2023 Elsevier Inc. All rights reserved..
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS) characterized by relapsing-remitting or progressive neurologic symptoms and focal white matter lesions. The hallmark of the disease is the dissemination of CNS lesions in space and time, which is defined by the McDonald criteria. MRI is an essential diagnostic and prognostic biomarker for MS which can evaluate the entire CNS. MS mimics must be excluded before a diagnosis of MS is made.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
|---|---|
| Enthalten in: |
Magnetic resonance imaging clinics of North America - 32(2024), 2 vom: 30. Apr., Seite 207-220 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gill, Sonia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Demyelinating disease |
|---|
| Anmerkungen: |
Date Completed 01.04.2024 Date Revised 01.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.mric.2023.11.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370446852 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370446852 | ||
| 003 | DE-627 | ||
| 005 | 20240401233147.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240331s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.mric.2023.11.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1359.xml |
| 035 | |a (DE-627)NLM370446852 | ||
| 035 | |a (NLM)38555137 | ||
| 035 | |a (PII)S1064-9689(23)00114-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gill, Sonia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Multiple Sclerosis Part 1 |b Essentials and the McDonald Criteria |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.04.2024 | ||
| 500 | |a Date Revised 01.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
| 520 | |a Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS) characterized by relapsing-remitting or progressive neurologic symptoms and focal white matter lesions. The hallmark of the disease is the dissemination of CNS lesions in space and time, which is defined by the McDonald criteria. MRI is an essential diagnostic and prognostic biomarker for MS which can evaluate the entire CNS. MS mimics must be excluded before a diagnosis of MS is made | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Demyelinating disease | |
| 650 | 4 | |a Imaging recommendations | |
| 650 | 4 | |a MRI | |
| 650 | 4 | |a McDonald criteria | |
| 650 | 4 | |a Multiple sclerosis | |
| 650 | 4 | |a Multiple sclerosis mimics | |
| 700 | 1 | |a Agarwal, Mohit |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Magnetic resonance imaging clinics of North America |d 1998 |g 32(2024), 2 vom: 30. Apr., Seite 207-220 |w (DE-627)NLM074659111 |x 1557-9786 |7 nnns |
| 773 | 1 | 8 | |g volume:32 |g year:2024 |g number:2 |g day:30 |g month:04 |g pages:207-220 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.mric.2023.11.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 32 |j 2024 |e 2 |b 30 |c 04 |h 207-220 | ||